Showing results (41-50 of 64) with videos related to

Sort By:
Pageof 7
Cancers|June 2, 2021
Circulating Tumor Cell Clusters Are Frequently Detected in Women with Early-Stage Breast CancerCarolina Reduzzi, Serena Di Cosimo, Lorenzo Gerratana, et al.
British Journal of Clinical Pharmacology|March 19, 2015
DPD and UGT1A1 deficiency in colorectal cancer patients receiving triplet chemotherapy with fluoropyrimidines, oxaliplatin and irinotecanFelicia Stefania Falvella, Stefania Cheli, Antonia Martinetti, et al.
Oncotarget|January 28, 2017
IL-8 and eNOS polymorphisms predict bevacizumab-based first line treatment outcomes in RAS mutant metastatic colorectal cancer patientsMariantonietta Di Salvatore, Filippo Pietrantonio, Armando Orlandi, et al.
Therapeutic Advances in Medical Oncology|April 17, 2023
The pan-immune-inflammation value is associated with clinical outcomes in patients with advanced TNBC treated with first-line, platinum-based chemotherapy: an institutional retrospective analysisLeonardo Provenzano, Riccardo Lobefaro, Francesca Ligorio, et al.
European Urology Oncology|September 23, 2019
Sorafenib Versus Observation Following Radical Metastasectomy for Clear-cell Renal Cell Carcinoma: Results from the Phase 2 Randomized Open-label RESORT StudyGiuseppe Procopio, Giulia Apollonio, Francesco Cognetti, et al.
International Journal of Cancer|August 24, 2023
Adding fasting-mimicking diet to first-line carboplatin-based chemotherapy is associated with better overall survival in advanced triple-negative breast cancer patients: A subanalysis of the NCT03340935 trialFrancesca Ligorio, Riccardo Lobefaro, Giovanni Fucà, et al.
British Journal of Cancer|November 23, 2021
Variant allele frequency in baseline circulating tumour DNA to measure tumour burden and to stratify outcomes in patients with RAS wild-type metastatic colorectal cancer: a translational objective of the Valentino studyPaolo Manca, Salvatore Corallo, Sara Lonardi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 1, 2016
Heterogeneity of Acquired Resistance to Anti-EGFR Monoclonal Antibodies in Patients with Metastatic Colorectal CancerFilippo Pietrantonio, Claudio Vernieri, Giulia Siravegna, et al.
JCO Precision Oncology|April 27, 2022
ALK Inhibitors in Patients With ALK Fusion-Positive GI Cancers: An International Data Set and a Molecular Case SeriesMargherita Ambrosini, Marzia Del Re, Paolo Manca, et al.
JCO Precision Oncology|November 10, 2022
Circulating Tumor DNA as a Marker of Minimal Residual Disease After Radical Resection of Colorectal Liver MetastasesFederica Marmorino, Michele Prisciandaro, Mirella Giordano, et al.
Pageof 7